ATE99541T1 - Reizvermeidende und desensibilisierende zusammensetzungen und verfahren zu deren anwendung. - Google Patents

Reizvermeidende und desensibilisierende zusammensetzungen und verfahren zu deren anwendung.

Info

Publication number
ATE99541T1
ATE99541T1 AT89114730T AT89114730T ATE99541T1 AT E99541 T1 ATE99541 T1 AT E99541T1 AT 89114730 T AT89114730 T AT 89114730T AT 89114730 T AT89114730 T AT 89114730T AT E99541 T1 ATE99541 T1 AT E99541T1
Authority
AT
Austria
Prior art keywords
methods
compositions
irritation
skin
desensitizing compositions
Prior art date
Application number
AT89114730T
Other languages
English (en)
Inventor
Walter P Smith
Nicholas J Pelliccione
Kenneth D Marenus
Daniel H Maes
Original Assignee
Estee Lauder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Estee Lauder Inc filed Critical Estee Lauder Inc
Application granted granted Critical
Publication of ATE99541T1 publication Critical patent/ATE99541T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
AT89114730T 1988-08-09 1989-08-09 Reizvermeidende und desensibilisierende zusammensetzungen und verfahren zu deren anwendung. ATE99541T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/230,444 US5028428A (en) 1988-08-09 1988-08-09 Anti-irritant and desensitizing compositions and methods of their use
EP89114730A EP0354554B1 (de) 1988-08-09 1989-08-09 Reizvermeidende und desensibilisierende Zusammensetzungen und Verfahren zu deren Anwendung

Publications (1)

Publication Number Publication Date
ATE99541T1 true ATE99541T1 (de) 1994-01-15

Family

ID=22865245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89114730T ATE99541T1 (de) 1988-08-09 1989-08-09 Reizvermeidende und desensibilisierende zusammensetzungen und verfahren zu deren anwendung.

Country Status (8)

Country Link
US (1) US5028428A (de)
EP (1) EP0354554B1 (de)
JP (1) JP2915931B2 (de)
AT (1) ATE99541T1 (de)
AU (1) AU613221B2 (de)
CA (1) CA1336892C (de)
DE (1) DE68912022T2 (de)
ES (1) ES2061828T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
KR100406124B1 (ko) * 2001-03-30 2003-11-15 주식회사 태평양 자외선에 의해 증가하는 프로스타글란딘을 억제하는성분과 멜라닌 합성을 억제하는 성분을 동시에 함유하는미백 화장료 조성물
US20050281806A1 (en) * 2004-06-16 2005-12-22 Collegium Pharmaceutical, Inc., Delaware Compositions for topical enzymatic debridement
US7399493B2 (en) 2004-07-16 2008-07-15 Wille John J Anti-irritant botanicals
CA2580329C (en) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
DE102006033321A1 (de) * 2006-07-17 2008-01-24 Westfälische Wilhelms-Universität Münster Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
EP2729148A4 (de) 2011-07-06 2015-04-22 Parkinson S Inst Zusammensetzungen und verfahren zur behandlung von symptomen bei patienten mit morbus parkinson
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
CA2977814A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
JP2022507660A (ja) 2018-11-16 2022-01-18 モーニングサイド ベンチャー インベストメンツ リミテッド 温度によって調節される経皮薬剤送達システム

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE328598C (de) * 1919-08-02 1920-11-02 Alfred Stephan Dr Verfahren zur Herstellung von Kolapraeparaten
DE961022C (de) * 1952-11-05 1957-03-28 Dr Fritz Schneider Verfahren zur Herstellung geschmacklich verbesserter und pharmakologisch wirksamer Pflanzenextrakte auf gaerungschemischem Wege
FR2128228A1 (en) * 1971-03-12 1972-10-20 Soreat Sa Essential amino acids/stabilized cola extract - with synergistic tonic effect
FR2499405A1 (fr) * 1981-02-10 1982-08-13 Biotherm Composition cosmetique amincissante et anti-cellulitique a base d'un extrait de plante contenant des saponines, un extrait d'arnica montana l. et d'un extrait de noix de cola et son procede d'application
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JPS62298523A (ja) * 1986-06-17 1987-12-25 Nitto Electric Ind Co Ltd 大海子、スズカケノキ含有安定化膏体
FR2609395B1 (fr) * 1988-02-23 1992-01-10 Serobiologiques Lab Sa Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee

Also Published As

Publication number Publication date
EP0354554B1 (de) 1994-01-05
CA1336892C (en) 1995-09-05
DE68912022D1 (de) 1994-02-17
DE68912022T2 (de) 1994-04-28
US5028428A (en) 1991-07-02
ES2061828T3 (es) 1994-12-16
EP0354554A3 (de) 1991-03-06
JPH02152928A (ja) 1990-06-12
AU3942989A (en) 1990-02-15
EP0354554A2 (de) 1990-02-14
HK1001323A1 (en) 1998-06-12
AU613221B2 (en) 1991-07-25
JP2915931B2 (ja) 1999-07-05

Similar Documents

Publication Publication Date Title
ATE99541T1 (de) Reizvermeidende und desensibilisierende zusammensetzungen und verfahren zu deren anwendung.
AR002974A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparación de una composición cosmética, farmacéutica y/o dermatológica para tratar las manchas rojas cutáneas de origen neurógeno, composición obtenida y procedimiento de tratamiento cosmético empleando dicho antagonista.
DK254787A (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
DK0671903T3 (da) Topisk og transdermalt tilførselssystem anvendende submikrone oliesfærer
DE69512685D1 (de) Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut
EP0382066A3 (de) Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
ATE173627T1 (de) Medizinische zusammensetzung
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
BR9706889A (pt) Uso de extratos de ginkgo biloba para a preparação de composições farmacêuticas e processo de tratamento cosmético usando um extrato de ginkgo biloba
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ES2054089T3 (es) Formulaciones orales liquidas.
BR9713044A (pt) Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.
DK0521057T3 (da) Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATE28188T1 (de) Antikonvulsive mittel.
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
DE69018570D1 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
ATE168004T1 (de) Juckreizstillendes mittel
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee